Join the Oncology Voice Network. Join for Free
The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)
Clinical Practice Liaison Field Medical Positions Medical Science Liaisons Transition to Industry Emotional Intelligence in Healthcare

The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)


Share This Article


Summary

In this episode, Jessica Johnson and Whitney Theiss from Neurocrine Biosciences join Tom Caravela to explore the transition from clinical roles to field medical positions, focusing on the Clinical Practice Liaison (CPL) role. They discuss the responsibilities and skills required for CPLs, comparing them to those of Medical Science Liaisons (MSLs). The episode delves into the challenges CPLs face, performance evaluation, and career progression, including the impact of remote work trends. Jessica and Whitney offer valuable advice for clinicians considering a transition, emphasizing the significance of emotional intelligence. The episode wraps up with key takeaways and closing thoughts.

My guests today are Jessica Johnson Director, Clinical Practice Liaisons and Whitney Tice, Clinical Practice Liaison at Neurocrine and we discuss the path from clinical practice to Field Medical.

In this episode we discuss:

  • Jessica and Whitney’s background
  • The transition from clinician into industry
  • Why are clinicians good candidates for Field Medical positions
  • What is a clinical practice liaison, responsibilities and difference from an MSL
  • What are the skill sets they look for in a CPL when hiring
  • What types of training is required for CPLs and the implemented in the organization
  • What makes a top-performing CPL
  • What can people aspire from the CPL role
  • Advice for a clinician trying to get into the role and how they can be successful

Click for Source
Clinical Practice Liaison, Field Medical Positions, Medical Science Liaisons, Transition to Industry, Emotional Intelligence in Healthcare

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN